Divalproex Sodium
Composition
It comprises 0.5 equivalent of sodium hydroxide and involves sodium hydrogen bis 2-propyl pentanoate. The active ingredient Divalproex sodium and the Passive ingredient are silicon dioxide and polydextrose.
Indications
Strokes, manic depression, and migraine headaches
Side effects
Stomach bloating, restlessness, excreting blood with urination, and hair loss
Precautions
Avoid occurrences like driving or lifting heavy things.
Contraindications
Extreme allergic reactions if contrasted with liver and kidney disorders.
Dosage and administration
Forms of medicine- Tablet, and capsule Both in an extended and delayed release With the proportion of tablet - 250 mg and capsule- 125 mg, suggested taking as per guidance until needed.
Countries
We are a pharmaceutical provider that collaborates globally. Highly in countries Qatar, Kuwait, Iran, Lebanon, and Belize
Available Forms
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai